Level:
Correct: 0
Incorrect: 0
Marks: 0/0
Exam Practice
Course:
Topics:
Avg
score:
–
Topics
done:
0/22

Vaccines, medicines and developing new medicines

Practise 20 exam-style questions on Vaccines, medicines and developing new medicines for OCR GCSE Combined Science (Biology Paper 8). Write your answer as you would in the exam and get it marked in seconds against the mark scheme, point by point, with the Study Helper on hand if you get stuck.

  • 20 questions
  • 1–6 marks each
  • Instant marking
  • No sign-up needed
20 questions, marked as you go

Sample questions with model answers

Here are 4 of the questions in this topic, each with a model answer, an explanation of why it earns the marks and the mark scheme an examiner would use.

Question 1

1 mark

Clinical testing of a new medicine takes place in several stages.

Which option describes the first stage of clinical testing?

Each option gives: who is given the medicine; how many people; the main aim.

Choose your answer.

  • A healthy volunteers; a large number; to find out if it treats the disease
  • B healthy volunteers; a small number; to check that it is safe
  • C patients with the disease; a large number; to find out if it treats the disease
  • D patients with the disease; a small number; to check that it is safe

Model answer

B

Explanation

Clinical testing builds up step by step: a few healthy volunteers (is it safe?), then a small number of patients (does it work, and what dose?), then large numbers of patients in double-blind trials. Using healthy volunteers first means any effects seen are caused by the medicine.

Mark scheme
  1. 1 mark

    B / healthy volunteers; a small number; to check that it is safe

    The only correct answer is B: the first clinical trial gives low doses to a small number of healthy volunteers, mainly to check that the medicine is safe and to look for side effects. A is not correct because a large number of people is not used at first, in case the medicine is harmful; C is not correct because large numbers of patients are tested later, to find out if the medicine works and compare it with a placebo or an existing medicine; D is not correct because the first trial uses healthy people, so that any side effects are not confused with the symptoms of a disease. ALLOW the letter or the option. If more than one option is given, do not award the mark.

Question 2

2 marks

Some antibiotics kill bacteria. Other antibiotics do not kill bacteria, but stop them from dividing.

Explain how an antibiotic that only stops bacteria from dividing can still cure a bacterial infection.

Model answer

The antibiotic stops the bacteria dividing, so their number stops increasing and the infection cannot spread. The bacteria already present are then destroyed by the immune system: lymphocytes make antibodies against them and phagocytes engulf and digest them.

Explanation

An antibiotic does not have to kill bacteria to work: if it stops them reproducing, the white blood cells can catch up and destroy the bacteria that are left. This is why such antibiotics work less well in people whose immune system is weak.

Mark scheme
  1. 1 mark

    the number of bacteria stops increasing / the bacteria cannot reproduce (so the infection cannot spread)

    IGNORE the antibiotic kills the bacteria.

  2. 1 mark

    the immune system / white blood cells destroy the bacteria that are already there

    ALLOW phagocytes engulf / digest the bacteria. ALLOW lymphocytes make antibodies against the bacteria. IGNORE white blood cells fight the bacteria.

Question 3

3 marks

Before an operation, a nurse cleans the patient's skin with an antiseptic. The patient is also given an antibiotic by injection just before the operation.

Explain why both an antiseptic and an antibiotic are used.

Model answer

The antiseptic kills microorganisms on the surface of the skin, so they are not carried into the wound when the skin, which is a barrier to pathogens, is cut. Antiseptics cannot be used inside the body because they would damage the body's own cells. The antibiotic is carried in the blood to the tissues, so it kills any bacteria that do get into the wound during the operation.

Explanation

Antiseptics and antibiotics act in different places: antiseptics on the outside of living tissue, antibiotics inside the body. Cutting the skin breaks a non-specific barrier, so both are used to reduce the risk of infection. A good answer says why each is needed rather than only what each one does.

Mark scheme
  1. 1 mark

    the antiseptic kills microorganisms / bacteria on the (surface of the) skin, so they do not enter the wound when the skin is cut

    1 mark for each point, max 3.

  2. 1 mark

    antiseptics cannot be used inside the body because they would also damage / kill body cells

  3. 1 mark

    the antibiotic is carried in the blood (to the tissues), so it kills / stops the growth of bacteria that get inside the body / into the wound

    ALLOW the antibiotic acts inside the body.

  4. 1 mark

    antiseptics also kill other types of microorganism, such as fungi or viruses, which antibiotics do not affect

  5. 1 mark

    the antiseptic does not kill every microorganism on the skin, so the antibiotic gives extra protection

    ALLOW neither one alone gives complete protection.

Question 4

4 marks

In March 2006, a new medicine called TGN1412 was given to people for the first time, in a clinical trial in London.

• Eight healthy male volunteers took part. Six were given the medicine and two were given a placebo.
• The six were given the medicine one after another, 10 minutes apart.
• The dose was 500 times smaller than a dose that had caused no harmful effects in monkeys during preclinical testing.

Within a few hours, all six volunteers given the medicine became seriously ill. They all survived after intensive care. The two volunteers given the placebo were not affected.

Evaluate the design of this trial and suggest how first trials of new medicines could be made safer.

Model answer

Some parts of the design were good: only a small number of healthy volunteers were used and the dose was 500 times smaller than one that had been safe in monkeys, so few people were put at risk. The placebo group showed that the illness was caused by the medicine, because the two volunteers given the placebo were not affected.

However, all six volunteers were given the medicine within an hour, 10 minutes apart, so by the time the first person became ill everyone had been dosed. The tests on monkeys also failed to predict the effect on humans.

To make first trials safer, the medicine should be given to one volunteer at a time, waiting long enough to check for effects before giving it to the next person, and starting with an even lower dose that is increased gradually.

Explanation

An evaluation gives strengths and weaknesses using the information, then a reasoned suggestion. The key weakness was dosing everyone so close together; after this trial, UK experts recommended that first doses be given to one volunteer at a time. It also shows the limits of animal testing: an animal's body may not respond in the same way as a human body.

Mark scheme
  1. 1 mark

    strength: (only) a small number of healthy volunteers were used, so few people were put at risk

    1 mark for each point, max 4. Max 3 if there is no suggestion of how to make first trials safer.

  2. 1 mark

    strength: a very low dose was used, based on the preclinical (animal) tests

    ALLOW the dose was 500 times smaller than a dose that was safe in monkeys.

  3. 1 mark

    strength: the placebo group showed that the illness was caused by the medicine

    ALLOW the volunteers given the placebo were not affected, so the medicine caused the illness.

  4. 1 mark

    weakness: all six were given the medicine within an hour / only 10 minutes apart, so the reaction in the first volunteer was not seen before the others were dosed

  5. 1 mark

    weakness: the tests on monkeys did not predict the effect on humans / monkeys may respond differently from humans

  6. 1 mark

    suggestion: give the medicine to one volunteer at a time, waiting (hours or days) to check for effects before dosing the next

  7. 1 mark

    suggestion: start with an even lower dose and increase it gradually (in later volunteers)

    ALLOW give the medicine more slowly / over a longer time.

  8. 1 mark

    suggestion: test the medicine on human cells / tissues (in the laboratory) before giving it to people

Ready to try the rest? Every answer you write is marked against the mark scheme, so you can see exactly where the marks are.

Study Helper Hints first, answers after you try

Stuck on this one? Ask for a hint and I’ll point you in the right direction, without giving the answer away. Once you’ve checked your answer, I’ll show you how the marks are awarded.